Kelly Martin skips to a new CEO suite as his last biotech team raises the white flag
A few months after stepping away from the helm of a biotech with a fluttering pulse, ex-Elan chief Kelly Martin is back in charge of another drug company with its own set of issues to deal with.
Radius Health in Waltham, MA announced that the 61-year-old Martin is stepping in to replace Jesper Hoeiland, the Novo vet who is now headed home to Denmark. Hoeiland was brought in to lead the charge on a new osteoporosis drug marketed as Tymlos, which hasn’t been going well.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.
